Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
367
-
Total 13F shares, excl. options
-
36.1M
-
Shares change
-
+23.2K
-
Total reported value, excl. options
-
$5.66B
-
Value change
-
+$7.04M
-
Put/Call ratio
-
0.61
-
Number of buys
-
204
-
Number of sells
-
-156
-
Price
-
$157.00
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2024
427 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q3 2024.
TransMedics Group, Inc. - Common Stock (TMDX) has 367 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.1M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.31M shares), VANGUARD GROUP INC (3.6M shares), FMR LLC (2.13M shares), Driehaus Capital Management LLC (1.44M shares), STATE STREET CORP (1.27M shares), Invesco Ltd. (1.09M shares), ArrowMark Colorado Holdings LLC (973K shares), MACQUARIE GROUP LTD (896K shares), LORD, ABBETT & CO. LLC (809K shares), and FIL Ltd (781K shares).
This table shows the top 367 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.